4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-25-100366
Chief Financial Officer sold 20,081 shares at an average $3.69 ($74,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2025-07-28 | Sale | −1,701 | $3.74 | $6,362 | 353,675 | D |
| Catinazzo Thomas Chief Financial Officer | 2025-07-29 | Sale | −18,380 | $3.68 | $67,638 | 335,295 | D |
| Open-market sales · 20,081 sh · avg $3.69 · $74,000 | |||||||
Loading xslF345X05/ownership.xml…